Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The entry **h-CPL Associates-maxillary sinusitis** refers to a clinical research context or specific Phase 4 trial (NCT00120237) managed by **CPL Associates** that evaluated the comparative efficacy and microflora impact of two established antibiotics, **telithromycin** and **azithromycin**, in adult patients with **acute maxillary sinusitis (AMS)**. Telithromycin is a ketolide antibiotic, while azithromycin is a macrolide; both agents exert their antimicrobial effects by binding to the 50S subunit of the bacterial ribosome, thereby inhibiting RNA-dependent protein synthesis. The study specifically investigated the speed of microbial eradication and the influence of these oral antibiotics on the endogenous oral microflora and the development of bacterial resistance patterns. CPL Associates acted as the lead sponsor for this post-marketing evaluation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on h-CPL Associates-maxillary sinusitis.